Biostax Corp.

As of September 30, 2024, Biostax Corp. has 84.35M shares outstanding.

As of September 30, 2024, Biostax Corp. maintains a current ratio of - -, meaning it holds the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -21.82, indicating conservative leverage, while an interest coverage ratio of -3.85 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2024. Return on assets (ROA) is negative at -314.10, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 4.00, a quick read on workforce productivity versus industry peers.

As of the close on September 25, 2026, Biostax Corp.'s stock has gained approximately 100.00% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.16.

Over the twelve months ended September 30, 2024, Biostax Corp. generated - - in revenue and converted that into -1.16M in net income, yielding earnings per share of -0.01. EBITDA reached -957,270.00, while operating income came in at -970,933.00.

As of September 30, 2024, Biostax Corp. holds - - in cash and equivalents against 1.16M in total debt, resulting in a net debt position of 1.16M. Total book value stands at -5.32M, with working capital of -5.33M providing operational flexibility.

Biostax Corp. produced -123,483.00 in operating cash flow over the twelve months ended September 30, 2024.

Biostax Corp.'s most recent stock split took place on May 6, 2021 with a 1000:1 split ratio.